Ken Griffin Ideaya Biosciences, Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 7,300 shares of IDYA stock, worth $274,188. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,300
Previous 3,600
102.78%
Holding current value
$274,188
Previous $128,000
150.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding IDYA
# of Institutions
206Shares Held
71.2MCall Options Held
29.8KPut Options Held
8.5K-
Black Rock Inc. New York, NY5.97MShares$224 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.86MShares$182 Million0.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.16MShares$156 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.05MShares$152 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X03.81MShares$143 Million0.09% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.81B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...